Health Care & Life Sciences » Pharmaceuticals | Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | Mutual Funds

Mutual Funds that own Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
3,973,997
1.81%
1,075,946
0%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
3,277,000
1.49%
0
0.02%
07/31/2018
Vanguard Total International Stock Index Fund
3,160,602
1.44%
0
0%
07/31/2018
Nanfang Global Select Fund
1,176,000
0.54%
1,176,000
0.63%
12/31/2017
900,000
0.41%
900,000
1.69%
12/31/2017
DFA Emerging Markets Core Equity Portfolio
712,000
0.32%
40,000
0.01%
04/30/2018
Atlantas SICAV - Far East
712,000
0.32%
142,000
1.44%
12/31/2017
WisdomTree Emerging Markets Small Cap Dividend Fund
538,000
0.25%
0
0.14%
09/06/2018
Canada Pension Plan
493,000
0.22%
-52,000
0%
03/31/2018
452,000
0.21%
452,000
0.54%
03/31/2018

About Guangzhou Baiyunshan Pharmaceutical Holdings Co.

View Profile
Address
No. 45 Sha Mian North Street
Guangzhou Guangdong 510130
China
Employees -
Website http://www.gpc.com.cn
Updated 07/08/2019
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern TCM, Great Commerce, and Great Health. The Great Southern TCM segment provides Chinese and Western medicine, chemicals for medicine, natural drugs, biological medicine.